type 1 diabetes, type 2 diabetes, healthy
Conditions
Interventions
The aim of this study is to verify differences in XOR activity in subjects with different conditions.
Sponsors
Hyogo college of medicine, innovative diabetes treatment
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: healthy volunteer, patients with diabetes
Exclusion criteria
Exclusion criteria: The exclusion criteria were as follows: 1) patients who took a a therapeutic agent for hyperuricemia, and 2) patients who were disqualified by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. XOR reactivity | — |
Secondary
| Measure | Time frame |
|---|---|
| hs-CRP, uric acid, urine albumin, urine protein, cystatin C, creatinin, glucose, CGM, etc | — |
Countries
Japan
Contacts
Public ContactYoshiki Kusunoki
Hyogo college of medicine Innovative diabetes treatment
Outcome results
None listed